OBI vs. VRP, ARIX, CIR, 4BB, BVXP, AVCT, SCLP, HVO, TILS, and VSN
Should you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), Avacta Group (AVCT), Scancell (SCLP), hVIVO (HVO), Tiziana Life Sciences (TILS), and Verseon (VSN). These companies are all part of the "biotechnology" industry.
Ondine Biomedical vs.
Ondine Biomedical (LON:OBI) and Verona Pharma plc (VRP.L) (LON:VRP) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation, dividends and community ranking.
In the previous week, Ondine Biomedical had 1 more articles in the media than Verona Pharma plc (VRP.L). MarketBeat recorded 1 mentions for Ondine Biomedical and 0 mentions for Verona Pharma plc (VRP.L). Ondine Biomedical's average media sentiment score of 0.00 equaled Verona Pharma plc (VRP.L)'saverage media sentiment score.
Verona Pharma plc (VRP.L) received 226 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 64.67% of users gave Verona Pharma plc (VRP.L) an outperform vote.
Verona Pharma plc (VRP.L) has lower revenue, but higher earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Verona Pharma plc (VRP.L), indicating that it is currently the more affordable of the two stocks.
20.6% of Ondine Biomedical shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Verona Pharma plc (VRP.L) has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. Verona Pharma plc (VRP.L)'s return on equity of 0.00% beat Ondine Biomedical's return on equity.
Summary
Ondine Biomedical beats Verona Pharma plc (VRP.L) on 6 of the 11 factors compared between the two stocks.
Get Ondine Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ondine Biomedical Competitors List
Related Companies and Tools
This page (LON:OBI) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy OBI Stock Free OBI Stock Alerts